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In a  previous paper we described a  mouse test for determining quanti- 
tatively  the  immunizing potency of  antirabies  vaccines  (1).  That  test 
showed commercial phenolized vaccines for the most part to be incapable 
of rendering mice immune to a  subsequent injection of rabies virus when 
employed in  doses comparable to  those for dogs or man with respect to 
body  weight.  Commercial  chloroformized vaccines  from  two  firms,  on 
the other hand, showed definite immunizing capacity provided two to five 
times the comparative dose was given intraperitoneally rather  than sub- 
cutaneously. 
These findings have now been checked in dogs by determining whether 
canine  vaccines which fail  to  immunize mice,  likewise fail  to  immunize 
dogs, and conversely, whether vaccines plus procedures which successfully 
immunize mice, will likewise immunize dogs.  The results of  these  tests 
thus far parallel those of the mouse tests (2,  3)  and are described here in 
detail. 
Technique for Testing Single Injection Antirabies Vaccines in Dogs 
According to reports of previous workers, rabies vaccines prove capable 
of inducing a well defined immunity in animals only if they are administered 
prophylactically, that is, prior to a  test injection of virus (5).  Moreover, 
no method of testing thus far reported, save the one in mice (1), has yielded 
quantitative data on the amount of immunity obtained per unit of vaccine. 
The following test  in  dogs has  been  developed after  the pattern  of  the 
mouse  test  to  provide  a  quantitative  result  under  conditions as  nearly 
natural as possible. 
Beagle dogs are used because of their small size and quiet disposition.  Animals of 
the same age, that is, 4  to 6 months, are chosen because age factors are known to in- 
fluence markedly the susceptibility and immunizability of mice to rabies (4), and they 
may play an equally important rCle with dogs.  The young animals are brought to the 
premises usually in batches of about thirty-five, placed in quarantine rooms, wormed~ 
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and given 10 to 15 cc. of distemper immune serum, followed 3 days later by one injec- 
tion of non-virulent distemper vaccine. 
About 7 days after their arrival, the animals are injected with the antirabies vaccines 
according  to the requirements of the experiment.  Five to fifteen animals  remain un- 
vaccinated, as controls. 
3 weeks later, all are tested for immunity by an injection into the neck muscles of 
each side with 0.25 cc. of virus properly diluted.  Dilutions are employed which are 
calculated to contain approximately 1,  10, or I00 lethal doses of virus (see Table I). 
The injected animals are transferred to single cages and observed 2 to 5 months.  Those 
found prostrate or dead are autopsied, their brains removed, and a portion of the latter 
is  inoculated intracerebrally into  mice for identification of the  virus.  Immunity is 
measured in terms of number of lethal doses resisted by at least 50 per cent of the dogs. 
The test virus, strain  15811, was obtained in  1937 from a  rabid street dog.  The 
virus-containing dog brain was passed intracerebraUy to Swiss mice.  When the animals 
became prostrate,  the  infected mouse brains  were  removed and  stored in  glycerin. 
Prior to  each experiment, the  glycerinated mouse brain  virus is  passed  once  intra- 
cerebrally through mice and the brains from the resulting prostrate animals are used to 
inoculate the test dogs.  When the non-vaccinated dogs become prostrate, their brains 
in turn are passed intracerebraUy through mice.  The brains of these mice are removed 
when the animals become prostrate and stored in glycerin to serve as virus for the next 
dog experiment.  Thus far, the infected mouse brains have continued to show large and 
numerous Negri bodies (Fig. 1). 
Intramuscular Virulence for Dogs of Rabies Virus 15811 
Experiments  with  various  routes  of  injecting  test  virus  into  dogs  re- 
sulted in the selection of the neck muscles as most natural and at the same 
time yielding the most measurable titration results.  English investigators 
preferred this  route  as  a  result of  20  years'  study of rabies  vaccines  (5). 
In our experience, titrations by the intracerebral route proved simple and 
gave  quantitative  results,  but  they  were  so  severe  that  vaccinated  dogs 
rarely withstood more than one lethal dose (6).  Titrations by the lingual 
route likewise gave results capable of reproduction in our hands, provided 
the vaccinated dogs were lightly anesthetized and injected with virus into 
the same portion of the tongue and at the same depth.  Titrations by the 
masseter muscle  route gave less  regular results in  duplicate  and  repeated 
tests.  Finally,  titrations  by  the  gastrocnemius  muscle  route  provided 
data too variable for quantitative studies. 
The results of titrations of rabies virus, No.  15811, into the neck muscles 
of beagle dogs, as described above, are shown in Tables I  and II. 
In Table I,  the results of each test are set forth under the headings of 
dilution of virus injected,  in terms  of survival  time in  days of  each fatal 
case,  plus the number of survivors.  Taken  together,  they reveal that  in 
four  tests  in  which  the  1:50  dilution  was  given,  a  total  of  seventeen of Test 
10 
Totals.. 
Com- 
bined 
totals  1:50 to 1:20 
Fate of dogs injected with 0.25 cc. of virus into neck muscles of right and left sides in dilutions 
1:50 
15"~16,26 
14,17,17, 
18, 22, 23 
11,11,11,13 
13,15,15,17 
17  of  17 
100% 
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TABLE  I 
Neck Muscle Titrations of Dog Passage Virus, 15811, in 5 Months Old Beagle Dogs 
1:40,000 
22,42,S,S 
22, S, S, S 
39, 42, S, S 
S,S,S,S,S 
5 of 17  m 
2~ 
5 of 17  - 
29% 
* Day of death from rabies following injection. 
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seventeen dogs succumbed (100 per cent); in two tests in which the 1:100 
dilution was given, nine of nine (100 per cent), and in three tests in which 
the  1:200  dilution was given, a  total of thirteen of sixteen dogs  (81  per 
cent) succumbed.  Again, in two tests in which the 1:400 dilutionwas given, 
four of seven (57 per cent) succumbed; in three in which the 1 : 500 dilution 
was given, ten of twelve (83 per cent) ; in one test with the 1 : 2,500 dilution, 
four of four (100 per cent) ; in four tests with the 1 : 4,000 dilution, seventeen 
of twenty-five (68 per cent), and in one test with the 1:10,000 dilution, five 
of  five  succumbed  (100  per  cent).  Finally,  in  four  tests  in  which  the 
1:40,000  dilution was given,  five of seventeen  (29  per  cent)  succumbed. 
Combining  these  figures  again  into  groups  in  which  the  mortality  was 
consistently:  (a)  close  to  100  per  cent;  (b)  less  than  100  per  cent  but 
TABLE  II 
Duration of Life of Dogs Following Injection of Dog Passage Rabies Virus, 15811, into the 
Neck Muscles of Young Beagle Dogs 
Duration of life of injected dogs 
11 to 19 days 
20 to 29  " 
30 to 60  " 
Survived 2 mos. 
Number and  per  cent  of  dogs  succumbing st  stated  intervals  following  injec- 
tion  of  virus  in  dilutions 
1:50 to 1:200 
No.  per ccn~ 
32/42  76 
7/42  17 
0  0 
3/42  7 
1:400 to 1:10,000 
No.  per cent 
29/53  55 
6/53  11 
5/53  9 
13/53  25 
1: 40,000 
No.  p~ cent 
0/17  0 
2/17  12 
3/17  18 
12/17  70 
greater than 50 per cent, and  (c) less than 50 per cent, we note that  (a) 
dilutions of 1:50  to  1:200 inclusive resulted in a  mortality of thirty-nine 
of forty-two tested dogs (93 per cent) ; (b) that dilutions of 1 : 400 to 1 : 10,000 
produced a  mortality of forty of fifty-three dogs  (75  per  cent),  and  (c) 
that dilutions of 1:40,000  brought about a  mortality of five of seventeen 
tested dogs (29 per cent).  From these figures we have taken dilution 1 : 200 
as the least dose fatal to practically 100 per cent of test animals and dilution 
1 : 10,000  as the least dose fatal to more than 50 per cent but less than 100 
per cent. 
These end points are in keeping with figures obtained by grouping the 
durations of life of the dogs shown in Table I. 
Table II shows that of forty-two dogs given the 1:50 to 1:200 dilutions 
of virus, 76 per cent died in 11 to 19 days, whereas of fifty-three given the 
1: 400 to 1: 10,000 dilutions, 55 per cent succumbed and of seventeen given 
the  1:40,000  dilution,  none succumbed within  this  11  to  19  day period. L.  T.  WEBSTER AND  J.  CASALS  723 
The percentages succumbing within 20 to 60 days were small  (0 to  18)  in 
all groups.  Finally,  of seventeen dogs  given  the  1:40,000  dilution,  none 
died within the 11 to 19 day period, 30 per cent in the 20 to 60 day period, 
and  70 per cent remained well.  In short,  there is an increase in survival 
time as well as survival percentages at  the  1:200,  1: 10,000,  and  1:40,000 
dilution levels of virus. 
Immunizing Potency of Commercial Canine Antirabies  Vaccines 
The above approximations of minimum lethal doses of virus were useful 
in evaluating our tests on dogs with commercial canine vaccines.  At the 
outset, animals following vaccination were tested against two to four doses 
of virus fatal to nearly  100 per cent of controls--l:200 to  1:50 dilutions. 
Subsequently,  however,  in  view  of  the  failure  of  vaccinated  animals  to 
withstand  this  dose,  they were  tested  against  a  much  smaller  amount  of 
virus,  namely,  two  to  twenty minimum  doses,  fatal  to more  than  50 per 
cent but less than  100 per cent of controls--the  1:4,000 to 1:400 dilutions. 
These  results  likewise  proved  negative,  as  illustrated  by  the  following 
series of protocols. 
Experiment I (Test  5).--5 cc. of phenolized vaccine No. 4 were injected subcutaneously 
into each of five dogs; 5 cc. of No. 5 phenolized vaccine into five dogs; 5 cc. of No. 8 
phenolized  and 5 cc. of No. 9 each subcutaneously into each of five dogs respectively. 
Four dogs received 5 cc. of No. 1 chloroformized vaccine subcutaneously, and five dogs 
remained unvaccinated as  controls.  3 weeks later each received 0.25 cc. of the 1:100 
dilution of No. 15811 virus into the neck muscles of each side. 
All five controls died of rabies  on the 12th to 18th days following injection of test 
virus (100 per cent)  (Table III).  The five dogs receiving  the No. 4 vaccine likewise 
died on the 9th to 26th days (100 per cent), and the five dogs receiving the No. 5 vaccine 
on the 12th to 18th days (100 per cent).  Four of the five receiving the No. 8 vaccine 
died on the 12th to 19th days (80 per cent), and one survived; similarly,  four of five 
receiving the No. 9 vaccine died on the 12th to 21st days (80 per cent), and one survived. 
In  contrast to this, only one of the  four  dogs  receiving  the  chloroformized  vaccine 
No. 1 succumbed (25 per cent). 
Table III shows  that none of the phenolized vaccines protected dogs to 
the  slightest  degree against  the  1:100  dilution  of test  virus,  whereas  the 
chloroformized vaccine afforded significant protection.  The 1 : 100 dilution 
is regarded as two minimum doses fatal to 100 per cent of controls. 
Experiment 2 (Test 7).--Six dogs, lot A, remained unvaccinated.  Three dogs, lot B, 
each received 5 cc. of phenolized  vaccine No. 3 subcutaneously.  Six dogs, lot C, each re- 
ceived 5 cc. of chloroformized vaccine No. 3 subcutaneously.  Five dogs, lot D, remained 
unvaccinated.  Four dogs, lot E, received 5 cc. of phenolized  vaccine No. 3 subcutane- 
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each received 0.25  cc.  of test  virus  diluted 1:200 into the neck muscles of each side. 
Lots D  and  E  received  the same dose of the 1:4,000 dilution, and lot F, the 1:40,000 
dilution. 
All six controls in lot A, receiving the 1:200 dilution, died of rabies on the 14th to 
22nd days following injection (100 per cent) (Table IV).  Similarly, two of the three in 
lot B receiving the phenolized No. 3 died on the 12th and 16th days (66 per cent), and 
five of six in lot C receiving the chloroformized vaccine died on the 13th to 23rd days 
(84 per cent).  Three of five controls in lot D receiving the 1:4,000 dilution died on the 
16th, 23rd, and 39th days respectively (60 per cent), and two of four in lot E receiving 
the phenolized No. 3 vaccine died on the 15th and 18th days (50 per cent).  Finally, of 
, the four control dogs in lot F given the 1:40,000 dilution, two died on the 22rid and 42rid 
days (50 per cent). 
TABLE  HI 
Immunizing  Effects of Canine  Antirabies  Vaccines  on Beagle Dogs 
Experiment 1, Test 5 
Treatment of dogs 
Fate of dogs inoculated into the neck muscles (right 
and left) with 0.25 co. of dog passage virus, 1581L 
diluted 1:I00 
Day of death following 
inoculation 
A.  No vaccine 
B.  Vaccine 4: Phenol, 5 cc. subc. 
C.  "  5:  "  "  "  " 
D.  "  8:  "  "  "  " 
E.  "  9:  "  "  "  " 
F.  "  1: Chloroform, 5 cc. subc. 
12, 15, 17, 18, 18 
9, 10, 15, 18, 26 
12, 15, 16, 17, 18 
12, 13, 14, 19, S 
12, 13, 14, 21, S 
13, S, S, S 
No. dead/  Dead 
No. injected --per 
s/s  10o 
5IS  100 
sis  100 
4/s  so 
4/5  80 
1/4  25 
S  ffi animal remained well following injection.  Survivors discarded after 60 days. 
In this,  as in the above experiment, there was no significant difference 
in the mortality of unvaccinated dogs given the  1:200  test dose (100  per 
cent) and in vaccinated dogs similarly tested (66 per cent and 84 per cent). 
Moreover, when the test dose was reduced to 1:4,000,  a point close to the 
minimum dose fatal to  50  to  100  per cent,  there was  still  no  significant 
protecting  effect of  the  vaccine,--controls  60  per  cent  as  compared  to 
vaccinated dogs 50 per cent. 
Experiment  3  (Test  8).--Four  dogs, lot A, remained unvaccinated.  Each of three 
dogs, lot B, received 5 cc. of phenolized vaccine No. 9 subcutaneously, and four dogs, lot 
C, each received 5 cc. of chloroformized vaccine No. 1 subcutaneously.  Five dogs, lot 
D, remained  unvaccinated;  three  dogs, lot  E,  each received  5 cc. of phenolized vac- 
cine No. 9 subcutaneously; four dogs, lot F, each received 5 cc. of phenolized vaccine 
No. 4 subcutaneously; and five dogs, lot G, each received 5 cc. of chloroformized vaccine L. T. WEBSTER  AND  J.  CASALS  725 
No. 1 subcutaneously.  The final lot, H, remained  unvaccinated.  3 weeks later each 
dog  in  lots  A, B,  and  C  received 0.25  cc.  of test virus diluted  1:400 into  the neck 
muscles of each side, each dog in lots D, E, F, and G, the same amount of virus diluted 
1:4,000,  and each dog in lot H, the same dose diluted 1:40,000. 
Two of the four unvaccinated dogs of lot A died of rabies on the 15th and 18th days 
respectively (50 per cent).  Two of the three vaccinated dogs in lot B died of rabies on 
the 13th and 14th days (66 per cent), and four of the four vaccinated dogs in lot C on 
the 15th,  17th,  19th,  and 22nd days (100 per cent).  Five of five unvaccinated dogs in 
lot D given the smaller dose of virus died on the 16th,  16th,  16th,  19th,  and 19th days 
respectively (100 per cent).  One of three vaccinated dogs in lot E died of rabies on the 
19th day (33 per cent), three of four vaccinated dogs in lot F likewise succumbed on the 
21st day (75 per cent), and two of five vaccinated dogs in lot G died on the 15th and 
TABLE IV 
Immuni,.ing Effects of Canine Antirabies  Vaccines on Beagle Dogs 
Experiment 2, Test 7 
Treatment of dogs 
A. No vaccine 
B. Vaccine 3: Phenol, 5 cc. subc. 
C.  "  3: Chloroform, 5 cc. subc. 
D. No vaccine 
E. Vaccine 3: Phenol, 5 cc. subc. 
F.  No vaccine 
S  =  animal remained well following 
Dilution of 
test virus 
1:200 
c~ 
1:4,000 
lc 
1:40,000[ 
Fate of dogs inoculated into the neck muscles 
(right and left) with 0.25 cc. of dog passage 
virus, 15811 
Day of death following 
inoculation 
14, 15, 18, 18, 21, 22 
12, 16, S 
13, 16, 17, 21, 23, S 
16, 23, 39, S, S 
15, 18, S, S 
22, 42, S, S 
No. 
dead/ 
No. in- 
jected 
6/6 
2/3 
s/6 
3/5 
2/4 
2/4 
Dead 
100 
66 
84 
60 
50 
50 
ln'ection.  Survivors discarded after 47 days. 
22nd days (40 per cent).  Finally, one of four unvaccinated dogs in lot H succumbed to 
the experimental injection on the 22nd day (25 per cent). 
This experiment shows no protective effect of any vaccine.  Lots A, B, 
and  C  received a  dilution  of  1:400,  calculated  as  twenty minimum doses 
fatal to 50 per cent but less than  100 per cent.  In this group, 50 per cent 
of the  controls,  A,  died  from the  test injection,  as compared with  66  and 
100  per  cent  of  the  vaccinated  B  and  C  lots  respectively.  Again,  lots 
D, E, F, and G  received a  still smaller test dose,  1 : 4,000, which is not more 
than  two minimum doses fatal to  51  to 99 per  cent.  100 per  cent of the 
controls died, as compared to 33, 75, and 40 per cent of the vaccinated dogs 
in lots E,  F,  and  G  respectively.  This 50 per  cent or more mortality on 
the  part  of  the  vaccinated  does  not  differ  significantly  from the  average 726  IMMUNIZING  POTENCY  OF ANTIRABIES  VACCINES 
figure  for  controls  given  this  dilution  (72  per  cent),  or  indeed  from  the 
somewhat irregular figure (100 per cent) in this test. 
Experiment 4 (Test 10).--Three dogs, lot A, five in lot B, and four in lot H remained 
unvaccinated.  Each of five dogs in lot C received 5 cc. of phenolized vaccine No. 10 sub- 
cutaneously, and each of five in lot D, 5 cc. of chloroformized vaccine No. 1 subcutane- 
ously.  3 weeks later, each dog of lot A  received 0.25 cc. of virus 15811 diluted 1:400 
into the neck muscles  of each side,  each of lots B, C, and D the same volume of virus 
diluted  1:4,000,  and each of lot H, 1:40,000. 
Two of the three control dogs, lot A, given the 1:400 dilution of virus died on the 
12th and 19th days (66 per cent).  Four of five controls, lot B, given the 1:4,000 dilution 
TABLE V 
Immunizing Effects of Canine Antirabies Vaccines on Beagle Dogs 
Experiment 3, Test 8 
Treatment of  dogs 
A. No vaccine 
B. Vaccine 9: Phenol, 5 cc. subc. 
C.  "  1: Chloroform, 5 cc. subc. 
D. No vaccine 
E. Vaccine 9: Phenol, 5 cc. subc. 
F.  "  4:  "  "  "  " 
G.  "  1: Chloroform, 5 cc. subc. 
H. No vaccine 
Dilution of 
test virus 
1:400  I 
~c 
1:4,000 
1:40,0001 
Fate of dogs inoculated into the neck 
muscles (right  and left)  with 0.25  cc. of dog 
passage vlrus,  15811 
No. dead/  D&y of death following  No. in- 
inoculation  jected  __ 
15, 18, S, S  2/4 
13, 14, S  2/3 
15, 17, 19, 22  4/4 
16, 16, 16, 19, 19  5/5 
19, S, S  1/3 
21, 21, 21, S  3/4 
15, 22, S, S, S  2/5 
22, S, S, S  1/4 
Dead 
~er cent 
50 
66 
100 
100 
33 
75 
4O 
25 
S  -- animal remained well following injection.  Survivors discarded after 41 days. 
of virus died on the 15th, 16th, 18th, and 30th days (80 per cent); four of five vaccinated 
dogs, lot C, given the same dilution of test virus, died on the 14th,  16th,  17th, and 43rd 
days (80 per cent), and two of the five vaccinated dogs, lot D, also given the same dilu- 
tion of test virus, died on the 15th and 19th days (40 per cent).  Two of the control lot, 
H, succumbed to the 1:40,000  dilution of virus (50 per cent). 
In this test  (Table VI), the mortality of the controls was 65 per cent as 
compared with 80 per cent and 40 per cent of the two vaccinated lots respec- 
tively,  showing  clearly,  as in  Experiments  2  and  3  above,  that  dogs vac- 
cinated with commercial rabies vaccines do not withstand the least amount 
of test  virus fatal  to  less than  100  per cent but  more than  50 per  cent of 
controls. 
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commercial canine vaccines given to dogs according to directions are com- 
bined in  Table VII.  Of the groups receiving  two to four times  the least 
dose  fatal  to  nearly  100  per  cent  of  controls,  the  thirty-seven  non-vac- 
cinated animals  showed a  mortality of  100 per cent,  the thirty-nine  given 
phenolized  vaccines,  82  per  cent,  and  the  thirty-six given  chloroformized 
TABLE  VI 
Immunizing  Effects of Canine Antirabies Vaccines on Beagle Dogs 
Experiment 4, Test 10 
Treatment of dogs 
A.  No vaccine 
C.  No. I0 phenolized vaccine 
D. No. 1 chloroformized vaccine 
H. No vaccine 
)ilution of 
test virus 
1:400 
1:4,000 
1:4,000 
1:4,000 
1:40,00( 
Fate of dogs inoculated into the neck 
muscles (right and left) with 0.25 cc. of dog 
passage virus, 15811 
Day of death following 
inoculation 
12, 19, S 
15, 16, 18, 30, S 
14, 16, 17, 43, S 
15, 19, S, S, S 
39, 42, S, S 
No.  dead 
No.  in- 
jected 
2/3 
4/5 
4/5 
2/5 
2/4 
Dead 
66 
80 
80 
4O 
50 
S  =  animal remained well following injection.  Survivors discarded after 50  days. 
TABLE  VII 
Summary of Mortalities  of Dogs Vaccinated with Commercial Canine  Vaccines and Tested 
Subsequently wit/, an Intramuscular Injection of Dog Passage Virus, 15811 
Vaccine employed 
None 
Phenol 
Chloroform 
Mortality from test virus in dilutions 
1:50 to 1:200  l:400to 1:4,000 
(2 to 4 X  least dose fatal to 93 
per cent of controls) 
No.  per cenl 
37 of 37  100 
32 of 39  82 
19 of 36  53 
(2 to 20 X  least dose fatal to 
51 to 99 per cent of controls) 
No.  #er cent 
30 of 38  79 
9 of 13  70 
4 of 10  40 
vaccines, 53 per cent.  Again, of the groups receiving a still smaller amount 
of  test virus  (two to twenty times the least dose fatal to less than  100 per 
cent but more than 50 per cent of controls), the thirty-eight non-vaccinated 
animals  showed a  mortality of 79 per cent,  the  thirteen  given phenolized 
vaccine,  70  per  cent,  and  the  ten  given  chloroformized  vaccines,  40  per 
cent.  These differences between vaccinated and non-vaccinated  dogs are 
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Immunizing  Potency  of  Commercial Canine  A ntirabies  Vaccines 
Administered in  Larger Doses and  by  the  Intraperitoneal Route 
Concurrently with the above experiments, tests have been made of the 
immunizing potency of canine vaccines administered in larger  doses and 
by  the  intraperitoneal  rather  than  the  subcutaneous  route.  Previous 
tests in mice  (1)  had shown that chloroformized vaccines are  capable of 
conferring a degree of immunity, provided two to five times the comparable 
dose per gram of body weight is given and the injections are made  intra- 
TABLE  VIII 
Immunizing  Effects of Canine Antirabies Vaccines on Beagle Dogs 
Experiment 5, Test 4 
Treatment of dogs 
A. No vaccine 
B. Vaccine 3: Chloroform, 1 dose, 20 cc., iper. 
C.  "  3: Chloroform, 1 dose, 10 cc., iper. 
D.  "  3: Chloroform, 2 doses, 5 cc. each, 
iper. 
E. Vaccine 3: Chloroform, 1 dose, 10 cc., subc. 
F.  "  3: Chloroform, 2 doses, 5 cc. each, 
subc. 
G. No vaccine 
Dilution of 
test v~us 
1:50 
~c 
1:500 
1:10,00~ 
Fate of dogs inoculated into the neck 
muscles (right and left) with 0.25 oc. of 
dog passage virus, 15811 
Day of death following 
inoculation 
13, 15, 15, 17 
34, 36, S, S, S 
S, S, S, S 
22, S, S, S 
22, 23, 54, S, S 
19, S, S 
12, 14, 15, 27, 52 
15, 18, 18, 23, 31 
No./  I 
dead  Dead 
No, 
njec! .'d 
per ¢c~ 
4/4  100 
2/5  40 
0/4  0 
1/4  25 
3/5  60 
1/3  33 
5/5  lo0 
5/S  100 
S  -- animal remained well following injection.  Survivors discarded after 70 days. 
peritoneally instead of subcutaneously.  The following protocol illustrates 
the type of experiment and results obtained in dogs. 
Experiment  5.--Four dogs,  lot  A,  remained unvaccinated.  Five dogs,  lot  B,  re- 
ceived chloroformized vaccine No. 3 in one dose of 20 cc. intraperitoneally.  Four dogs, 
lot C, received the same vaccine in one dose,  10 cc., intraperitoneally;  four dogs in lot D 
received the vaccine in two doses of 5 cc. each intraperitoneally;  five dogs in lot E each 
received one dose,  10 cc., subcutaneously, and three dogs, lot F, two doses of 5 cc. each 
subcutaneously.  Five dogs in lot G and five in lot H remained unvaccinated.  3 weeks 
later each dog in lots A to F inclusive received 0.25 cc. of virus 15811, diluted 1:50, into 
the neck muscles of each side.  Dogs in lot G received the same dose of a 1:500 dilution, 
and lot H, a 1 : 10,000 dilution. 
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the 13th, 15th, 15th, and 17th days respectively (100 per cent).  Two of the five dogs 
in lot B, given  20 cc. of vaccine intraperitoneally, died on the 34th and 36th days (40 per 
cent).  No dogs in lot  C, given 10 cc. of vaccine intraperitoneaUy, succumbed (0 per 
cent).  Only one of four dogs in lot D given two 5 cc. doses intraperitoneally died (25 per 
cent).  Three of five dogs in lot E, given 10  cc. of vaccine subcutaneously, died on 
the 22nd, 23rd, and 54th days respectively (60 per cent).  One of three dogs given two 
doses of 5 cc. each subcutaneously died on the 19th day (33 per cent).  Five controls 
given the 1:500 dilution of test virus died on the 12th, 14th, 15th, 27th, and 52nd days 
(100per cent).  Five dogs given the 1:10,000 dilution  of test virus  likewise died on 
the 15th, 18th, 18th, 23rd, and 31st days (100 per cent). 
The  test  shows  (Table  VIII)  that  chloroformized vaccine  immunizes 
dogs fairly well (ten of thirteen, 77 per cent), if given intraperitoneally in 
at least double the standard 5 cc. dose.  If given subcutaneously in simi- 
larly large doses,  the result,  although less striking  (four of eight,  50 per 
cent),  is  still  significant.  This  protection  was  obtained  against  a  large 
amount of test virus--in  this  single test,  at least 200  times, although in 
average tests not more than four times, the least dose fatal to 100 per cent. 
DISCUSSION 
The development of a  quantitative method for measuring the immuniz- 
ing potency of antirabies vaccines in dogs affords an opportunity to test 
rabies  vaccines  critically under  conditions  approaching  those  in  nature. 
The failure of commercial phenolized and chloroformized canine vaccines 
to immunize dogs under the above experimental conditions weighs against 
their present value in the field.  On the other hand, the fact that chloro- 
formized vaccines in larger doses, administered intraperitoneally, success- 
fully immunize suggests that the development of a potent, practical vaccine 
is  not an  impossibility. 
The dog test has likewise been useful in checking the results of the mouse 
test  (1).  Phenolized vaccines found to  be negative in mice proved like- 
wise negative in dogs and chloroformized vaccines, equivocal or irregular 
in mice, proved the same in dogs.  Finally, larger doses of chloroformized 
vaccines injected intraperitoneally proved effective, though  irritative,  in 
both mice and dogs.  Thus the results of the dog test have paralleled those 
of the mouse test. 
The parallelism between results in dogs and those previously reported in 
mice (1)  establishes the reliability of the mouse test as an index of the im- 
munizing effect of rabies  vaccines in  other animal  species.  Accordingly 
the mouse test  becomes a  simple,  inexpensive, and practical tool for the 
testing of routine or experimental vaccines. 730  IMMUNIZING  POTENCY  OF ANTIRABIES  VACCINES 
CONCLUSIONS 
1.  A  quantitative  method  is  described for  testing  the  immunizing  po- 
tency of anfirabies vaccines in dogs. 
2.  Phenolized,  single-injection,  canine  vaccines  from  seven  manufac- 
turers, when administered to dogs according to directions, failed to protect 
them against the least measurable amount of test virus fatal to 50 per cent 
or  more  of  controls.  Chloroformized  vaccines  from  two  of  three  manu- 
facturers, under the same conditions, gave equivocal or suggestive results. 
3.  Commercial  chloroformized  vaccines  in  10  cc.  doses,  injected  intra- 
peritoneally  rather  than  subcutaneously into  dogs,  conferred a  significant 
degree of immunity but proved temporarily irritative to the peritoneum. 
4.  These results of canine vaccines in dogs parallel closely those already 
reported in mice. 
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EXPLANATION OF PLATE 35 
FIG. 1. Negri bodies in  Ammon's horn  of W-Swiss mouse injected  intracerebraUy 
with the brain of a non-vaccinated dog in Experiment  10, which had been inoculated 
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